You have 9 free searches left this month | for more free features.

Ichthammol

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Dexamethasone, Leflunomide, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Jan 10, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Dexamethasone, Isatuximab)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Jul 21, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 1, 2022

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Detroit (drug, device, other, procedure)

Recruiting
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Refractory Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Elotuzumab, Pomalidomide)

Suspended
  • Refractory Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 18, 2021

AL Amyloidosis Trial in United States (Bortezomib, Cyclophosphamide, Dexamethasone)

Recruiting
  • AL Amyloidosis
  • Orange, California
  • +5 more
May 3, 2022

Dyspnea, Malignant Tumor Trial in Houston (Dexamethasone, Placebo, Questionnaire Administration)

Active, not recruiting
  • Dyspnea
  • Malignant Neoplasm
  • Houston, Texas
  • +2 more
Feb 10, 2022

Malignant Brain Tumor, Metastatic Malignant Tumor in the Brain, Recurrent Malignant Brain Tumor Trial in Duarte (Dexamethasone)

Recruiting
  • Malignant Brain Neoplasm
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 3, 2022

Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

Recruiting
  • Recurrent AL Amyloidosis
  • Refractory AL Amyloidosis
  • Bone Marrow Aspiration and Biopsy
  • +3 more
  • Duarte, California
  • +3 more
Jul 6, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Malignant Solid Tumor Trial in Atlanta (drug, procedure, radiation)

Recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • Metastatic Malignant Solid Neoplasm
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 13, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Recurrent Plasma Cell Myeloma Trial in Rochester (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 19, 2022

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Recurrent Plasma Cell Myeloma Trial in Columbus (Dexamethasone, HDAC Inhibitor AR-42, Laboratory Biomarker Analysis)

Completed
  • Recurrent Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jun 10, 2021

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Mar 22, 2022

Advanced Malignant Tumor, Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Active, not recruiting
  • Plasma Cell Myeloma
  • Daratumumab
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 17, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 30, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Bendamustine Hydrochloride, Carfilzomib,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bendamustine Hydrochloride
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 7, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
  • +1 more
Aug 19, 2022

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 12, 2022

Plasmacytoma, POEMS Syndrome Trial in Rochester (Dexamethasone, Ixazomib Citrate, Lenalidomide)

Active, not recruiting
  • Plasmacytoma
  • POEMS Syndrome
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 26, 2022